1. Home
  2. FBIO

FBIO

Fortress Biotech Inc.

Logo Fortress Biotech Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-17-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

Founded: 2006 Country:
United States
United States
Employees: N/A City: BAY HARBOR ISLANDS
Market Cap: 35.5M IPO Year: N/A
Target Price: $33.33 AVG Volume (30 days): 308.4K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -8.47 EPS Growth: N/A
52 Week Low/High: $1.24 - $12.75 Next Earning Date: 05-13-2024
Revenue: $84,513,000 Revenue Growth: 11.58%
Revenue Growth (this year): -10.35% Revenue Growth (next year): 69.43%

Share on Social Networks: